These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9251604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S, Reddy R.
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic prospects for paucibacillary leprosy.
    Katoch K.
    Indian J Lepr; 2000 Sep; 72(3):351-61. PubMed ID: 11105276
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P, Manimozhi N, Jesudasan K.
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B.
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH, Ji BH, Guelpa-Lauras CC, Perani EG, N'Deli LN.
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [Abstract] [Full Text] [Related]

  • 12. [How should leprosy be treated?].
    Mahé A.
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN, Kumar S, Jain S, Bhattacharya SN.
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract] [Full Text] [Related]

  • 16. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
    Naik SS, Bhanage ND, Sawant KV, Ganapati R.
    Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
    [Abstract] [Full Text] [Related]

  • 17. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K, Thappa DM, Kadhiravan T.
    Indian J Lepr; 2001 Jul; 73(2):167-9. PubMed ID: 11579653
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.